Back Pain News and Research

Latest Back Pain News and Research

Acorda reports fourth quarter net revenue of $133.1 million for full year ended December 31, 2010

Acorda Therapeutics, Inc. today announced its financial results for the fourth quarter and full year ended December 31, 2010.

17 Feb 2011

Medtronic: Kyphon Balloon Kyphoplasty provides better back pain relief in cancer patients

Medtronic Inc., today announced the results of the first randomized, controlled trial comparing Kyphon Balloon Kyphoplasty with non-surgical care in treating spinal fractures in cancer patients. The study found that Kyphon Balloon Kyphoplasty provided cancer patients better back-specific function, more rapid back pain relief and improved quality of life compared with non-surgical care one month after treatment.

17 Feb 2011

Study finds worse outcomes in workers undergoing spinal fusion surgery

For workers' compensation patients with chronic low back pain, spinal fusion surgery leads to worse long-term outcomes—including a lower rate of return to work—compared to nonsurgical treatment, suggests a study in the February 15th issue of Spine. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

16 Feb 2011

Patients with chronic low-back pain can benefit from spinal manipulation

If you're suffering from chronic lower back pain, a new review of existing research finds that spinal manipulation − the kind of hands-on regimen that a chiropractor might perform on you − is as helpful as other common treatments like painkillers.

15 Feb 2011

Research: 75% of nonmilitary group medically evacuated for nonbattle injuries did not return to field

After analyzing data on 2,155 private contractors, diplomats and other civilians supporting war efforts in Iraq and Afghanistan who were medically evacuated out of combat zones, researchers have found they are more likely to be evacuated for noncombat-related injuries, but more likely to return to work in-country after treatment for these conditions.

15 Feb 2011

Zogenix completes enrollment in ZX002 Phase 3 study in opioid-experienced adults with moderate to severe pain

Zogenix, Inc. announced today the completion of enrollment in its pivotal Phase 3 efficacy study (Study 801) of ZX002. ZX002 is a novel, oral, single-entity, controlled-release formulation of hydrocodone for the treatment of moderate to severe pain in patients requiring around-the-clock opioid therapy for an extended period of time.

10 Feb 2011

Afinitor plus BSC doubles progression-free survival in patients with advanced pancreatic neuroendocrine tumors

The New England Journal of Medicine (NEJM) published a study today that shows Afinitor® (everolimus) tablets plus best supportive care (BSC) more than doubled progression-free survival (PFS), or time without tumor growth, versus placebo plus BSC in patients with advanced pancreatic neuroendocrine tumors (NET).

10 Feb 2011

Genentech's OCEANS Phase III study of Avastin in platinum-sensitive ovarian cancer meets primary endpoint

Genentech, a member of the Roche Group, announced today that OCEANS, a Phase III study evaluating Avastin® (bevacizumab) in combination with chemotherapy (carboplatin and gemcitabine) followed by continued use of Avastin alone until disease progression in women with previously treated (recurrent), platinum-sensitive ovarian cancer, met its primary endpoint.

8 Feb 2011

USPTO issues key patent to ISTO's NuQu product for degenerative disc disease treatment

ISTO Technologies, Inc. announced today that the United States Patent and Trademark Office has granted the company a key patent covering the primary technology for ISTO's NuQu product.

7 Feb 2011

AHRQ finds 3.4 million emergency department visits for back problems in the U.S.

Roughly 3.4 million emergency department visits - an average of 9,400 a day - were specifically for back problems at U.S. hospitals in 2008, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

4 Feb 2011

New study indicates predisposition to lumbar disc disease could be inherited

Symptomatic lumbar disc disease, a condition caused by degeneration or herniation of the discs of the lower spine, may be inherited, according to a new study published in the Journal of Bone and Joint Surgery.

3 Feb 2011

ACP finds diagnostic imaging for low back pain does not improve patients health

The American College of Physicians has found strong evidence that routine imaging for low back pain with X-ray or advanced imaging methods such as CT scan or MRI does not improve the health of patients.

2 Feb 2011

Abbott fourth quarter worldwide sales increase 13.4% to nearly $10 billion

Abbott today announced financial results for the fourth quarter ended Dec. 31, 2010.

27 Jan 2011

UWE researcher receives two CSPCT grants to improve clinical delivery of treatments

A researcher from the University of the West of England has been awarded two grants to fund work that will encourage people with serious joint conditions to move and excercise more.

24 Jan 2011

Pain services severely inadequate: report

The Patients Association has urged the Government to create a clear care pathway for chronic pain services throughout the National Health Service. This came in after a survey of more than 4,000 patients revealed significant shortcomings in care.

11 Jan 2011

TransPharma reports positive results from ViaDerm-Calcitonin Phase 1 trial for musculoskeletal disorders

TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today successful results of a Phase I clinical trial of its self-applied ViaDerm-Calcitonin product for the treatment of musculoskeletal disorders such as osteoarthritis and musculoskeletal pain.

11 Jan 2011

Dendreon provides U.S. commercialization and European strategy updates for PROVENGE

Dendreon Corporation today announced several updates regarding the U.S. commercialization of PROVENGE® (sipuleucel-T), the European strategy for PROVENGE, and progress on its pipeline.

7 Jan 2011

Study finds fusion surgeries designed to alleviate pain from degenerating discs not effective

Alfred O. Bonati, M.D., internationally known orthopedic surgeon and founder of The Bonati Spine Institute, reports that, in his experience, the failure rates for open back surgery, as recently reported by the Ohio Bureau of Workers' Compensation, are not out of line.

5 Jan 2011

Celgene announces regulatory submissions for blood cancer therapies REVLIMID and ISTODAX

Celgene International Sàrl announced regulatory submissions for its blood cancer therapies REVLIMID (lenalidomide) and ISTODAX (romidepsin).

5 Jan 2011

Study suggests new experimental drug is better than standard morphine

A little-known morphinelike drug is potentially more potent, longer lasting and less likely to cause constipation than standard morphine, a study led by a Loyola University Health System anesthesiologist has found.

5 Jan 2011

Back Pain News and Research

Latest Back Pain News and Research

Acorda reports fourth quarter net revenue of $133.1 million for full year ended December 31, 2010

Medtronic: Kyphon Balloon Kyphoplasty provides better back pain relief in cancer patients

Study finds worse outcomes in workers undergoing spinal fusion surgery

Patients with chronic low-back pain can benefit from spinal manipulation

Research: 75% of nonmilitary group medically evacuated for nonbattle injuries did not return to field

Zogenix completes enrollment in ZX002 Phase 3 study in opioid-experienced adults with moderate to severe pain

Afinitor plus BSC doubles progression-free survival in patients with advanced pancreatic neuroendocrine tumors

Genentech's OCEANS Phase III study of Avastin in platinum-sensitive ovarian cancer meets primary endpoint

USPTO issues key patent to ISTO's NuQu product for degenerative disc disease treatment

AHRQ finds 3.4 million emergency department visits for back problems in the U.S.

New study indicates predisposition to lumbar disc disease could be inherited

ACP finds diagnostic imaging for low back pain does not improve patients health

Abbott fourth quarter worldwide sales increase 13.4% to nearly $10 billion

UWE researcher receives two CSPCT grants to improve clinical delivery of treatments

Pain services severely inadequate: report

TransPharma reports positive results from ViaDerm-Calcitonin Phase 1 trial for musculoskeletal disorders

Dendreon provides U.S. commercialization and European strategy updates for PROVENGE

Study finds fusion surgeries designed to alleviate pain from degenerating discs not effective

Celgene announces regulatory submissions for blood cancer therapies REVLIMID and ISTODAX

Study suggests new experimental drug is better than standard morphine

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Back Pain News and Research

Latest Back Pain News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in